Evidence-Based Toxicology is a gold open-access journal, for systematic reviews, study protocols, research methods, expert commentaries, and other publications that use or develop so-called "evidence-based methods" in toxicology and environmental health. With our rigorous, constructive open review processes and an author-first editorial philosophy, you can trust us to handle your manuscript professionally and fairly. EBT is the official journal of the Evidence-Based Toxicology Collaboration.
Company Details
- Employees
- 2
- Founded
- 2023
- Address
- Baltimore, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Academic publishing.
- HQ
- Baltimore
Evidence-Based Toxicology Questions
Evidence-Based Toxicology's website is https://www.tandfonline.com/journals/tebt20
Evidence-Based Toxicology's LinkedIn profile is https://www.linkedin.com/company/ebt-journal
Evidence-Based Toxicology has
2 employees.
View email and phone details for 2
employees at Evidence-Based Toxicology.
Evidence-Based Toxicology's industry is
Research Services
Evidence-Based Toxicology's top competitors are
Pharma D-Mand,
Synbioc Research Group, Ghent University,
Xamã Ai,
The Environmental Justice Lab Podcast,
Vanta Stem,
Evidence-Based Toxicology Collaboration,
Organic Initiative,
Cell Alternativ,
Rebiocycle,
Marine@ugent.
Evidence-Based Toxicology's categories are Research Services
Evidence-Based Toxicology's founding year is 2023
